MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-08-0021997
Sakshi Pharmaceuticals Private Limited
Sakshi Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹39.45 Cr
▲ 6% YoY
Net profit · FY 2026
₹1.44 Cr
Net margin 3.6%
EBITDA · FY 2026
₹2.26 Cr
EBITDA margin 5.7%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.52 Cr
Issued & subscribed
Open charges
₹4.5 Cr
Satisfied ₹10.37 Cr
Company age
31 yrs
Est. 1995
Directors on board
2
As per MCA filings
About Sakshi Pharmaceuticals Private Limited
Data last updated:
Sakshi Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 April 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC067859. Its GSTIN is 07AABCS2802E3ZT (Delhi). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.52 Cr. It is led by directors Sakshi Jain and Ish Kumar Chadha.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at S – 22 Green Park Extension, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2026, the company reported a revenue of ₹39.45 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.44 Cr (net margin 3.6%) and EBITDA of ₹2.26 Cr (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 119% over five years.
As per MCA filings, the company has open charges of ₹4.5 Cr and satisfied charges of ₹10.37 Cr on record.
Sakshi Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0021997). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74899DL1995PTC067859
Registration Number 067859
Incorporation Date 26 April 1995
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-08-0021997
Key People
Sakshi Jain Director Ish Kumar Chadha Director Recognitions & Rankings of Sakshi Pharmaceuticals
Contact details
Sakshi Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS – 22 Green Park Extension, New Delhi, Delhi, India – 110016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sakshi Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sakshi Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Sakshi Pharmaceuticals are wholesale and retail trade; repair of motor vehicles and motorcycles and professional, scientific and technical activities. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | |
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Sakshi Pharmaceuticals Private Limited, buy the company report.
Financials of Sakshi Pharmaceuticals Private Limited
FY 2026 filings availableSakshi Pharmaceuticals Private Limited reported revenue of ₹39.45 Cr (up 6% YoY) for FY 2026.
Revenue · FY 2026
₹39.45 Cr ▲ 6%
Net profit · FY 2026
₹1.44 Cr margin 3.6%
EBITDA · FY 2026
₹2.26 Cr margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 7%
5 years · compounded
▲ 119%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 41%
5 years · compounded
▲ 81%
Revenue has grown at a compounded annual rate (CAGR) of 119% over five years, including 6% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹39.45 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.44 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sakshi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sakshi Pharmaceuticals Private Limited
Sakshi Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sakshi Jain Also directs: Cosy Pharmaceuticals Private Limited, Shivangi Remedies Private Limited, Shagun Towers Private Limited and 5 more | Director | 15 Nov 2019 | 6 Years 11 Months | Current |
| Ish Kumar Chadha Also directs: QSR Medical Agencies Private Limited, Medico Agencies Private Limited, Shagun Drugs Private Limited and 1 more | Director | 02 Apr 2021 | 5 Years 7 Months | Current |
Auditor
Sakshi Pharmaceuticals Private Limited is audited by Praveen Hans & Company for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Praveen Hans & Company | FY 2026 | 008871N |
Shareholding
The shareholding of Sakshi Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sakshi Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.5 Cr
Satisfied charges
₹10.37 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Nov 2021 | 100513927 | Others | ₹4.5 Cr | Open | |
| 09 Sep 2021 | 100486428 | Hdfc Bank Limited | ₹10 Cr | Satisfied | |
| 26 Mar 2013 | 10424839 | Corporation Bank | ₹37 Lakh | Satisfied |
To see the full charge records of Sakshi Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Sakshi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sakshi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sakshi Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCS2802E3ZT | Delhi | Active | 04 Dec 2019 |
To see the full GST registrations and return filing status of Sakshi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sakshi Pharmaceuticals Private Limited has 7 board changes on record since 2019: 2 appointments and 5 cessations. The latest: Ish Kumar Chadha ceased to be Additional Director on 30 Nov 2021.
Filing
Sakshi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi.
Charges
A charge with Others of Rs. 4.50 Cr registered on 13 Nov 2021 with Charge ID 100513927 was modified on 31 Oct 2025.
AGM
Sakshi Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Charges
A charge registered on 09 Sep 2021 via Charge ID 100486428 with Hdfc Bank Limited was fully satisfied on 11 Apr 2022.
Charges
A charge registered on 26 Mar 2013 via Charge ID 10424839 with Corporation Bank was fully satisfied on 14 Mar 2022.
Ceased
Ish Kumar Chadha ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 4.50 Cr with Charge ID 100513927 was registered on 13 Nov 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100486428 was registered on 09 Sep 2021.
Ceased
Tanya Jain ceased to be Director.
Appointed
Ish Kumar Chadha was appointed as Director.
Ceased
Sakshi Jain ceased to be Additional Director.
Ceased
Rakesh Jain ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
Sakshi Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 April 1995 (31+ years old) and is registered under CIN U74899DL1995PTC067859.
Sakshi Pharmaceuticals has 2 current directors:
- Sakshi Jain - Director
- Ish Kumar Chadha - Director
The latest financial statements of Sakshi Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sakshi Pharmaceuticals is 07AABCS2802E3ZT, registered in Delhi. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Sakshi Pharmaceuticals is U74899DL1995PTC067859. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sakshi Pharmaceuticals was incorporated on 26 April 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
Ish Kumar Chadha ceased to be Additional Director on 30 Nov 2021. Tanya Jain ceased to be Director on 10 Apr 2021. Ish Kumar Chadha was appointed as Director on 02 Apr 2021. Sakshi Pharmaceuticals has 7 board changes on record in total.
Yes, Sakshi Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0021997).
The registered office of Sakshi Pharmaceuticals is at S – 22 Green Park Extension, New Delhi, Delhi, India – 110016.
Sakshi Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages